Inhibition of CYP1A1 Alleviates Colchicine-Induced Hepatotoxicity

Beiwei Zhu, Ruoyue Huang, Jingyi Duan, Wen Huang, Yan Cheng, Fei Li
2024-01-09

SCID:  54.1/ztqgxy2j
Colchicine, a natural compound extracted from Colchicum autumnale, is a phytotoxin, but interestingly, it also has multiple pharmacological activities. Clinically, colchicine is widely used for the treatment of gouty arthritis, familial Mediterranean fever, cardiovascular dysfunction and new coronary pneumonia. However, overdose intake of colchicine could cause lethal liver damage, which is a limitation of its application. Therefore, exploring the potential mechanism of colchicine-induced hepatotoxicity is meaningful. Interestingly, it was found that CYP1A1 played an important role in the hepatotoxicity of colchicine, while it might also participate in its metabolism. Inhibition of CYP1A1 could alleviate oxidative stress and pyroptosis in the liver upon colchicine treatment. By regulating CYP1A1 through the CASPASE-1-GSDMD pathway, colchicine-induced liver injury was effectively relieved in a mouse model. In summary, we concluded that CYP1A1 may be a potential target, and the inhibition of CYP1A1 alleviates colchicine-induced liver injury through pyroptosis regulated by the CASPASE-1-GSDMD pathway.
Publication Details
Publication Date
2024-01-09
Journal
Publisher
ISSN
Access Type
Author Information
Authors
Beiwei Zhu
Ruoyue Huang
Jingyi Duan
Wen Huang
Yan Cheng
Fei Li
Explore More Research
Use the citation graph to discover related papers and expand your research horizons.
Click any node to explore
Download PDF
100%